Robert Panek is a Principal Medical Writer specializing in early clinical development at ICON, where they lead writing and regulatory projects for phases 1 through 3. With over 20 years of experience in pharmaceutical research and development, they have expertise in immune disorders, oncology, diabetes, and cardiovascular diseases. Previously, Robert held positions at organizations such as PRA Health Sciences and Pfizer, contributing significant advancements in drug discovery and clinical documentation. They are currently pursuing a Ph.D. in Pharmacology from The University of Kansas and have completed a postdoctoral fellowship in Pharmacology and Cell Biology.
This person is not in any teams
This person is not in any offices